If you had more than $300 million to try and fix the healthcare industry, how would you do it?
San Antonio—Cybersecurity is a fast growing area of the insurance industry as insurers capitalize on the smattering of fear-inciting headlines, from the Equifax and Facebook breaches to the ever-present risk of ransomware.
Large companies like Nationwide Mutual Insurance offer businesses... Read more »
Warp Drive Bio started up in 2012 with a potential buyer, Sanofi, already in place. Six years later the Cambridge, MA, company is being acquired—by another startup, Revolution Medicines.
The companies aren’t disclosing financial details of the acquisition, other than to... Read more »
Blockchain and cryptocurrency advocates have been waiting for large financial institutions to shed their wariness and begin investing meaningful amounts of money into the emerging technology. The sector may have gotten a significant catalyst on Monday, when Fidelity Investments announced it... Read more »
Reflexion Health, which has developed a “virtual physical therapy” system for patients recovering from surgery, said results from a randomized controlled clinical trial completed by nearly 300 people showed patients who used the technology saved the healthcare industry an average of... Read more »
More days than not, Michael Colaneri’s home is a hotel room. So innovations like “geolocation” sensors that automatically unlock his room door and adjust the thermostat when he’s nearby make the constant change easier—sometimes.
“My experience has been exceptionally inconsistent,” he... Read more »
MIT is making another significant investment in artificial intelligence. The Institute announced Monday that it will establish a new college on its Cambridge, MA, campus—the MIT Stephen A. Schwarzman College of Computing—that will serve as an interdisciplinary hub for advancing ideas... Read more »
Roche, the world’s biggest cancer drug company, selected the technology of startup SQZ Biotechnologies to help it develop new cellular therapies for cancer. Three years after that drug alliance started, the partners are now broadening the immune cells covered by... Read more »
Byron Reese, the Gigaom publisher and successful entrepreneur who has written extensively on how technology impacts society, says he believes the biggest future breakthroughs are likely to come from universities and startup companies, rather than large, publicly traded ones.
“I think... Read more »
Zendesk is ramping up its investments in Madison, WI, which is home to the customer-service software company’s second-largest U.S. office.
Nivolumab (Opdivo) recently became the first immunotherapy ever approved for people with small cell lung cancer (SCLC), a particularly aggressive form of the deadly disease. But the lead given to its developer, Bristol-Myers Squibb, may be short-lived.
Nearly four years after investors snapped up new shares of Juno Therapeutics in a $265 million IPO, cancer immunotherapy remains a hot ticket. Like Juno, Allogene Therapeutics just pulled in a massive IPO haul, nearly $300 million. And like Juno, Allogene... Read more »
The University of Michigan has been named one of the 100 most innovative university systems in the world in a new report issued Thursday by Reuters. Reuters said the list ranks “educational institutions doing the most to advance science, invent new technologies,... Read more »
In another wave of account shutdowns, Facebook announced Thursday that it disabled more than 800 pages and accounts to prevent groups that disguised their identities from flooding its network with inauthentic content—some of it hyper-partisan political messages.
Whether from embarrassing parties or sobering surveys, the biotech gender gap problem has made plenty of headlines the past couple years. The industry’s largest trade group, the Biotechnology Industry Organization (BIO), is trying to encourage its more than 1,000 member companies... Read more »